Medizinische Universität Graz - Research portal
Department of Internal Medicine
Division of Oncology
Total: 532 project(s)
of which:
- Current: 152 project(s)
- Completed: 375 project(s)
- Publicly accessible: 94 project(s)
- Funded projects: 107 project(s)
- scient. event(s): 0 project(s)
- 516 project(s) as leading unit and 16 project(s) as Med Uni Graz-partner unit
Project management at chosen institution:
- Project type: EN: Forschungsförderung
- Project Leader: Dutta Sayantanee
- MUG Research Units: Division of Oncology ;
- Funded by: Österreichische Krebshilfe Steiermark, Rudolf-Hans-Bartsch-Straße 15-17, 8042 Graz, Austria
- Duration: 01.04.2025-31.03.2027
- Project type: EN: Forschungsförderung
- Project Leader: Jäger Vanessa
- MUG Research Units: Division of Oncology ;
- Funded by: Österreichische Gesellschaft für Hämatologie und Medizinische Onkologie, AKH-Wien, Klinik für Innere Medizin I Währinger Gürtel 18-20, 1090 Wien, Austria
- Duration: 01.08.2024-31.12.2026
- Project type: EN: Forschungsförderung
- Project Leader: Vosberg Sebastian
- MUG Research Units: Division of Oncology ;
- Funded by: MEFOgraz , Neue Stiftingtalstraße 6 WEST, 8010 Graz, Austria
- Duration: 01.02.2022-31.12.2026
- Project type: EN: Forschungsförderung
- Project Leader: Jost Philipp
- MUG Research Units: Division of Oncology ;
- Funded by: Christian Doppler Forschungsgesellschaft (CDG), Sensengasse 1, 1090 Wien, Austria
- Duration: 01.01.2026-31.12.2027
- Project type: EN: Forschungsförderung
- Project Leader: Dengler Michael
- MUG Research Units: Division of Oncology ;
- Funded by: Christian Doppler Forschungsgesellschaft (CDG), Sensengasse 1, 1090 Wien, Austria
- Duration: 01.01.2026-31.12.2027
- Project type: EN: Forschungsförderung
- Project Leader: Jost Philipp
- MUG Research Units: Division of Oncology ;
- Funded by: FWF, Fonds zur Förderung der Wissenschaftlichen Forschung, Georg-Coch-Platz 2, 1010 Wien, Austria
- Duration: 01.01.2024-22.12.2027
- Project type: EN: Forschungsförderung
- Project Leader: Dengler Michael
- MUG Research Units: Division of Oncology ;
- Funded by: Verein für Krebskranke an der Medizinischen Universität Graz, Auenbruggerplatz 15, 8036 Graz, Austria
- Duration: 01.10.2024-31.12.2026
- Project type: EN: Forschungsförderung
- Project Leader: Dutta Sayantanee
- MUG Research Units: Division of Oncology ;
- Funded by: Gilead Sciences, 2 Roundwood Avenue , South Building, Stockley Park, Uxbridge, UB11 1AF Middlesex, United Kingdom
- Duration: 01.02.2024-31.07.2026
- Project type: EN: Forschungsförderung
- Project Leader: Vizar Cisarova Katarina
- MUG Research Units: Division of Oncology ;
- Funded by: MEFOgraz , Neue Stiftingtalstraße 6 WEST, 8010 Graz, Austria
- Duration: 01.02.2025-31.01.2026
- Project type: EN: Forschungsförderung
- Project Leader: Dutta Sayantanee
- MUG Research Units: Division of Oncology ;
- Funded by: Leukämiehilfe Steiermark, Kainbach bei Graz, Austria
- Duration: 01.06.2025-01.06.2026
- Project type: EN: Forschungsförderung
- Project Leader: Jäger Vanessa
- MUG Research Units: Division of Oncology ;
- Funded by: Österreichische Krebshilfe Steiermark, Rudolf-Hans-Bartsch-Straße 15-17, 8042 Graz, Austria
- Duration: 01.04.2025-31.03.2027
- Project type: EN: Forschungsförderung
- Project Leader: Jost Philipp
- MUG Research Units: Division of Oncology ;
- Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
- Duration: 01.12.2023-30.11.2026
- Project type: EN: Forschungsförderung
- Project Leader: Hasenleithner Samantha
- MUG Research Units: Division of Oncology ;
- Funded by: Land Steiermark, Graz, Austria
- Duration: 01.10.2025-30.09.2026
- Project type: EN: Forschungsförderung
- Project Leader: Dengler Michael
- MUG Research Units: Division of Oncology ;
- Funded by: FWF, Fonds zur Förderung der Wissenschaftlichen Forschung, Georg-Coch-Platz 2, 1010 Wien, Austria
- Duration: 01.10.2025-30.09.2028
- Project type: EN: Forschungsförderung
- Project Leader: Jost Philipp
- MUG Research Units: Division of Oncology ;
- Funded by: FWF, Fonds zur Förderung der Wissenschaftlichen Forschung, Georg-Coch-Platz 2, 1010 Wien, Austria
- Duration: 01.06.2024-10.07.2028
- Project type: EN: Forschungsförderung
- Project Leader: Moik Florian
- MUG Research Units: Division of Oncology ;
- Funded by: International Society on Thrombosis and Haemostasis, 610 Jones Ferry Rd Ste. 205, Carrborro, United States (USA)
- Duration: 01.10.2025-30.09.2027
- Project type: EN: Forschungsförderung
- Project Leader: Rinnerthaler Gabriel
- MUG Research Units: Division of Oncology ;
- Funded by: Österreichische Krebshilfe Steiermark, Rudolf-Hans-Bartsch-Straße 15-17, 8042 Graz, Austria
- Duration: 01.04.2025-31.03.2027
- Project type: EN: Forschungsförderung
- Project Leader: Jost Philipp
- MUG Research Units: Division of Oncology ;
- Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
- Duration: 01.10.2024-30.09.2027
-
A novel cytokine based therapeutic strategy for treating acute myeloid leukemia
-
Boosting immunotherapy in non-small cell lung cancer
-
Characterizing the epigenetics of lung cancer progression to inform
personalized treatment
-
Christian Doppler (CD) Laboratory for Activation of Immunogenic Cell Death in Lung Cancer
-
Christian Doppler (CD) Laboratory for Activation of Immunogenic Cell Death in Lung Cancer
-
Deciphering the role of necroptosis-induced inflammation in lung adenocarcinomas
-
Identifying novel lung cancer drivers: Unravelling the functional role of genes affected by large copy number gains
-
Identifying novel targets to combat aberrant TP53 mediated therapeutic resistance in acute myeloid leukemia using CRISPRko screens
-
In silico characterization of 1q21 amplification in advanced lung adenocarcinoma
-
In vivo competition of AML cells harboring different TP53 aberrations
-
Innovative approaches to strengthen immunotherapy in lung cancer
-
INTERACT-EUROPE 100
-
Multi-omics for personalized oncology at the Molecular Tumor Board
-
Search for combinational therapy to target clonal haematopoiesis in solid malignancies
-
TARgetinG disease pErsisTence and progression of
MyeloProliferative Neoplasms
-
Thromboembolic Events with Amivantamab-based Therapies in Patients with Lung Cancer
-
Tumor biological and immunological characterization of localized therapy-refractory triple-negative breast carcinomas
-
TWINNING FOR EXCELLENCE TO ADVANCE RESEARCH IN THE ACTIVATION OF
ANTI-TUMOR IMMUNE RESPONSE AFTER ELECTROCHEMOTHERAPY COMBINED WITH GENE
ELETROTRANSFER OF pDNA ENCODING ICIs
Project management at other institution:
- Project type: EN: Forschungsförderung
- Project Leader: Plass Markus
- MUG Research Units: Diagnostic and Research Institute of Pathology ;
- Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
- Duration: 01.09.2022-31.08.2026
- Project type: EN: Forschungsförderung
- Project Leader: Jost Philipp
- MUG Research Units: Comprehensive Cancer Center Graz ;
- Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
- Duration: 01.10.2024-30.09.2028
- Project type: EN: Forschungsförderung
- Project Leader: Balihodzic Amar
- MUG Research Units: Division of Oncology ;
- Funded by: Österreichische Akademie der Wissenschaften, ÖAW, Dr. Ignaz Seipel-Platz 2, A-1010 Wien, Austria
- Duration: 01.09.2025-31.08.2027
- Project type: EN: Forschungsförderung
- Project Leader: Terbuch Angelika
- MUG Research Units: Division of Oncology ;
- Funded by: Ludwig Boltzmann Gesellschaft, Nußdorfer Straße 64, 1090 Wien, Austria
- Duration: 01.01.2026-31.12.2029
- Project type: EN: Forschungsförderung
- Project Leader: Andritsch Elisabeth
- MUG Research Units: Division of Medical Psychology, Psychosomatics and Psychotherapeutic Medicine ; Division of Oncology ;
- Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
- Duration: 01.09.2024-31.08.2027
-
AI powered Data Curation & Publishing Virtual Assistant
-
EUnetCCC
-
Identfying novel vulnerabilites in lung cancer utlizing advanced CRISPR approaches
-
Multimodal Strategies to Target Key Challenges in Bladder Cancer
-
tAckLing menTal Health cancer patients and their families: digital solutions for bEtter cAre